Artia Global Partners LP Quant / Systematic

CIK: 0001937964 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value ($000): $415,641 (100.0% shares, 0.0% debt)

Holdings (37)

VERONA PHARMA PLC 21.0%
Value ($000) $87,411 Shares 924,204 Est. Cost $67.66 Unrealized
INSM INSMED INC 18.2%
Value ($000) $75,753 Shares 752,712 Est. Cost $72.29 Unrealized +5.8%
ARGX ARGENX SE 10.4%
Value ($000) $43,167 Shares 78,311 Est. Cost $527.57 Unrealized
SLNO SOLENO THERAPEUTICS INC 10.0%
Value ($000) $41,423 Shares 494,424 Est. Cost $48.81 Unrealized +53.3%
LLY ELI LILLY & CO 5.8%
Value ($000) $23,932 Shares 30,700 Est. Cost $826.69 Unrealized -6.4%
BSX BOSTON SCIENTIFIC CORP 4.0%
Value ($000) $16,670 Shares 155,200 Est. Cost $100.78 Unrealized +0.4%
MERUS N V 3.8%
Value ($000) $15,609 Shares 296,750 Est. Cost $42.88 Unrealized
DGX QUEST DIAGNOSTICS INC 3.5%
Value ($000) $14,679 Shares 81,717 Est. Cost $165.04 Unrealized +4.3%
AZN ASTRAZENECA PLC 3.2%
Value ($000) $13,330 Shares 190,752 Est. Cost $69.76 Unrealized
VERONA PHARMA PLC 2.1%
Value ($000) $8,682 Shares 91,800 Est. Cost $67.66 Unrealized
XBI SPDR SER TR 2.0%
Value ($000) $8,293 Shares 100,000 Est. Cost Unrealized
TRVI TREVI THERAPEUTICS INC 1.7%
Value ($000) $7,176 Shares 1,311,840 Est. Cost $6.22 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 1.6%
Value ($000) $6,838 Shares 20,970 Est. Cost $197.76 Unrealized +39.9%
UGL PROSHARES TR II 1.4%
Value ($000) $5,823 Shares 168,000 Est. Cost Unrealized
REGN REGENERON PHARMACEUTICALS 1.3%
Value ($000) $5,602 Shares 10,671 Est. Cost $556.12 Unrealized 0.0%
SRRK SCHOLAR ROCK HLDG CORP 1.1%
Value ($000) $4,473 Shares 126,285 Est. Cost $38.47 Unrealized -18.4%
INSM INSMED INC 1.0%
Value ($000) $4,026 Shares 40,000 Est. Cost $72.29 Unrealized +5.8%
RVMD REVOLUTION MEDICINES INC 0.9%
Value ($000) $3,833 Shares 104,190 Est. Cost $48.13 Unrealized -20.2%
SPRINGWORKS THERAPEUTICS INC 0.7%
Value ($000) $3,004 Shares 63,930 Est. Cost $48.87 Unrealized
EYPT EYEPOINT PHARMACEUTICALS INC 0.7%
Value ($000) $2,980 Shares 316,700 Est. Cost $9.59 Unrealized -28.0%
ABBV ABBVIE INC 0.6%
Value ($000) $2,691 Shares 14,500 Est. Cost $182.67 Unrealized 0.0%
VKTX VIKING THERAPEUTICS INC 0.6%
Value ($000) $2,557 Shares 96,479 Est. Cost $28.19 Unrealized -6.6%
ASND ASCENDIS PHARMA A/S 0.5%
Value ($000) $2,113 Shares 12,240 Est. Cost $159.57 Unrealized
TGTX TG THERAPEUTICS INC 0.5%
Value ($000) $1,962 Shares 54,515 Est. Cost $28.70 Unrealized +29.7%
VRTX VERTEX PHARMACEUTICALS INC 0.5%
Value ($000) $1,959 Shares 4,400 Est. Cost $460.83 Unrealized 0.0%
RARE ULTRAGENYX PHARMACEUTICAL IN 0.4%
Value ($000) $1,521 Shares 41,830 Est. Cost $36.05 Unrealized 0.0%
UTHR UNITED THERAPEUTICS CORP DEL 0.3%
Value ($000) $1,437 Shares 5,000 Est. Cost $342.70 Unrealized -12.8%
MREO MEREO BIOPHARMA GROUP PLC 0.3%
Value ($000) $1,288 Shares 475,361 Est. Cost $3.23 Unrealized
PTGX PROTAGONIST THERAPEUTICS INC 0.3%
Value ($000) $1,269 Shares 22,951 Est. Cost $36.55 Unrealized +31.3%
XENE XENON PHARMACEUTICALS INC 0.3%
Value ($000) $1,252 Shares 40,000 Est. Cost $46.00 Unrealized -29.1%
BHVN BIOHAVEN LTD 0.3%
Value ($000) $1,129 Shares 80,000 Est. Cost $17.82 Unrealized 0.0%
RNAM AVIDITY BIOSCIENCES INC 0.2%
Value ($000) $983 Shares 34,600 Est. Cost $29.81 Unrealized 0.0%
KNSA KINIKSA PHARMACEUTICALS INTL 0.2%
Value ($000) $808 Shares 29,200 Est. Cost $25.46 Unrealized 0.0%
MLYS MINERALYS THERAPEUTICS INC 0.1%
Value ($000) $556 Shares 41,100 Est. Cost $14.49 Unrealized 0.0%
NAMS NEWAMSTERDAM PHARMA COMPANY 0.1%
Value ($000) $495 Shares 27,319 Est. Cost $18.24 Unrealized 0.0%
JANX JANUX THERAPEUTICS INC 0.1%
Value ($000) $462 Shares 20,000 Est. Cost $52.89 Unrealized -50.2%
TVTX TRAVERE THERAPEUTICS INC 0.1%
Value ($000) $457 Shares 30,900 Est. Cost $20.30 Unrealized -18.3%